Modified pyrimidine glucocorticoid receptor modulators
AssigneeCorcept Therapeutics, Inc.
InventorsRobin D. Clark, Nicolas C. Ray, Karen Williams, Peter H. Cracket, Gwen Hickin, David A. Clark
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel class of modified pyrimidine compounds and compositions and methods of using the compounds as glucocorticoid receptor modulators.
Claims19
A method of treating a disorder or condition through modulating a glucocorticoid receptor, the method comprising administering to a subject in need of such treatment an effective amount of a compound having the formula:
- wherein,
- m and n are integers independently selected from 0 to 2, such that the nitrogen heterocycle including m and n is a piperidinyl ring;
- R1 is a member selected from unsubstituted phenyl and phenyl substituted with R1B;
- R2 is a member selected from hydrogen, —CN, and —OH;
- R3 is a member selected from unsubstituted benzyl and benzyl substituted with R3A;
- R3A and R1B are members independently selected from halogen, hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, —CN, —CF3, —OR5, —SR6, —NR7R8, -L3-C(O)R9, and -L4-S(O)2R10, wherein
- R5, R6, R7, and R8 are members independently selected from hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, and unsubstituted heteroaryl, wherein
- R7 and R8 are optionally joined to form a ring with the nitrogen to which they are attached,
- R9 and R10 are members independently selected from hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, and —NR11R12, wherein
- R11 and R12 are independently selected from the hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, and
- L3 and L4 are members independently selected from a bond and —NH—;
- and
- R4 is a member selected from hydrogen and unsubstituted alkyl;
- wherein
- each aryl is independently selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, and 4-biphenyl,
- each heterocycloalkyl is independently selected from the group consisting of 1-(1,2,5,6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-piperazinyl, and 2-piperazinyl, and
- each heteroaryl is independently selected from the group consisting of 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl, 2-benzimidazolyl, 5-indolyl, 1-isoquinolyl, 5-isoquinolyl, 2-quinoxalinyl, 5-quinoxalinyl, 3-quinolyl, and 6-quinolyl.
(canceled)
(canceled)
-10. (canceled)
-15. (canceled)
(canceled)
(canceled)
-72. (canceled)
A method of modulating a glucocorticoid receptor including the steps of contacting a glucocorticoid receptor with a compound and detecting a change in the activity of the glucocorticoid receptor, said compound having the formula:
- wherein,
- m and n are integers independently selected from 0 to 2, such that the nitrogen heterocycle including m and n is a piperidinyl ring;
- R1 is a member selected from unsubstituted phenyl and phenyl substituted with R1B;
- R2 is a member selected from hydrogen, —CN, and —OH;
- R3 is a member selected from unsubstituted benzyl and benzyl substituted with R3A;
- R3A and R1B are members independently selected from halogen, hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, —CN, —CF3, —OR5, —SR6, —NR7R8, -L3-C(O)R9, and -L4-S(O)2R10, wherein
- R5, R6, R7, and R8 are members independently selected from hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, and unsubstituted heteroaryl, wherein
- R7 and R8 are optionally joined to form a ring with the nitrogen to which they are attached,
- R9 and R10 are members independently selected from hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, and —NR11R12, wherein
- R11 and R12 are independently selected from the hydrogen, unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, and
- L3 and L4 are members independently selected from a bond and —NH—;
- and
- R4 is a member selected from hydrogen and unsubstituted alkyl;
- wherein
- each aryl is independently selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, and 4-biphenyl,
- each heterocycloalkyl is independently selected from the group consisting of 1-(1,2,5,6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-piperazinyl, and 2-piperazinyl, and
- each heteroaryl is independently selected from the group consisting of 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4-imidazolyl, pyrazinyl, 2-oxazolyl, 4-oxazolyl, 2-phenyl-4-oxazolyl, 5-oxazolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl, 5-benzothiazolyl, purinyl, 2-benzimidazolyl, 5-indolyl, 1-isoquinolyl, 5-isoquinolyl, 2-quinoxalinyl, 5-quinoxalinyl, 3-quinolyl, and 6-quinolyl.
Dependencies are inferred from the claim text.